Aicuris Anti Infect Drug Patent Portfolio

Aicuris Anti Infect owns 1 orange book drug protected by 5 US patents Given below is the list of Aicuris Anti Infect's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9119786 Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations 26 Sep, 2032
Active
US9340535 N-[5-(Aminosulfony1)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mesylate Monohydrate 26 Sep, 2032
Active
US9889124 Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations 26 Sep, 2032
Active
USRE49697 26 Sep, 2032
Active
US8784887 Pharmaceutical Preparation Of N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide 18 Jul, 2029
Active


Aicuris Anti Infect's Family Patents


Family Patents



Aicuris Anti Infect Drug List

Given below is the complete list of Aicuris Anti Infect's drugs and the patents protecting them.


1. Hovilpri

Hovilpri is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9119786 Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations 26 Sep, 2032
(5 years from now)
Active
US9340535 N-[5-(Aminosulfony1)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mesylate Monohydrate 26 Sep, 2032
(5 years from now)
Active
US9889124 Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations 26 Sep, 2032
(5 years from now)
Active
USRE49697 26 Sep, 2032
(5 years from now)
Active
US8784887 Pharmaceutical Preparation Of N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide 18 Jul, 2029
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hovilpri's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List